Regulations.gov document
Determinations of Regulatory Review Periods for Purposes of Patent Extensions: ALPROLIX
Notice · FDA-2014-E-2351 · posted Jun 8, 2016
Key facts
| Document ID | FDA-2014-E-2351-0004 |
|---|---|
| Title | Determinations of Regulatory Review Periods for Purposes of Patent Extensions: ALPROLIX |
| Document type | Notice |
| Subtype | Determinations |
| Agency | FDA |
| Docket | FDA-2014-E-2351 |
| Posted | Jun 8, 2016 |
| Federal Register citation | 81 FR 36928 |
| FR document number | 2016-13526 |
| Comment period opens | Jun 8, 2016 |
| Comments due | Dec 6, 2016 |
| Effective date | Jun 8, 2016 |
At a glance
- 1–9 Pages
- No Open for comment
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: